A further mutation in PMS2 (p.Met1?; pathogenic mutation in National Center for Biotechnology Information (NCBI) ClinVar16) was identified in the population but not in any CRC patients diagnosed during 2000–2009. The gene discussed is PMS2; the disease is colorectal carcinoma.